Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use

被引:37
作者
Hoffman, SL [1 ]
Doolan, DL [1 ]
Sedegah, M [1 ]
Aguiar, JC [1 ]
Wang, RB [1 ]
Malik, A [1 ]
Gramzinski, RA [1 ]
Weiss, WR [1 ]
Hobart, P [1 ]
Norman, JA [1 ]
Margalith, M [1 ]
Hedstrom, RC [1 ]
机构
[1] VICAL INC,SAN DIEGO,CA 92121
关键词
DNA vaccine; malaria; pre-erythrocytic stage;
D O I
10.1016/S0264-410X(96)00273-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Data generated in the Plasmodium yoelii rodent model indicated that plasmid DNA vaccines encoding the P. yoelii circumsporozoite protein (PyCSP) or 17 kDa hepatocyte erythrocyte protein (PyHEP17) were potent inducers of protective CD8(+) T cell responses directed against infected hepatocytes. Immunization with a mixture of these plasmids circumvented the genetic restriction of protective immunity and induced additive protection. A third DNA vaccine encoding the P. yoelii sporozoite surface protein 2 (PySSP2) also induced protection. The P. falciparum genes encoding the homologues of these three protective P. yoelii antigens as well as another P. falciparum gene encoding a protein that is expressed in infected hepatocytes have been chosen for the development of a human vaccine. The optimal plasmid constructs for human use will be selected on the basis of immunogenicity data generated in mice and nonhuman primates. We anticipate that optimization of multi-gene P. falciparum DNA vaccines designed to protect against malaria by inducing CD8(+) cells that target infected hepatocytes will require extensive clinical trials during the coming years. Published by Elsevier Science Ltd.
引用
收藏
页码:842 / 845
页数:4
相关论文
共 10 条
  • [1] PLASMODIUM-YOELII - 17-KDA HEPATIC AND ERYTHROCYTIC STAGE PROTEIN IS THE TARGET OF AN INHIBITORY MONOCLONAL-ANTIBODY
    CHAROENVIT, Y
    MELLOUK, S
    SEDEGAH, M
    TOYOSHIMA, T
    LEEF, MF
    DELAVEGA, P
    BEAUDOIN, RL
    AIKAWA, M
    FALLARME, V
    HOFFMAN, SL
    [J]. EXPERIMENTAL PARASITOLOGY, 1995, 80 (03) : 419 - 429
  • [2] Identification and characterization of the protective Hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1
    Doolan, DL
    Hedstrom, RC
    Rogers, WO
    Charoenvit, Y
    Rogers, M
    delaVega, P
    Hoffman, SL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) : 17861 - 17868
  • [3] Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8(+) T cell-, interferon gamma-, and nitric oxide-dependent immunity
    Doolan, DL
    Sedegah, M
    Hedstrom, RC
    Hobart, P
    Charoenvit, Y
    Hoffman, SL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) : 1739 - 1746
  • [4] A LIVER-STAGE-SPECIFIC ANTIGEN OF PLASMODIUM-FALCIPARUM CHARACTERIZED BY GENE CLONING
    GUERINMARCHAND, C
    DRUILHE, P
    GALEY, B
    LONDONO, A
    PATARAPOTIKUL, J
    BEAUDOIN, RL
    DUBEAUX, C
    TARTAR, A
    MERCEREAUPUIJALON, O
    LANGSLEY, G
    [J]. NATURE, 1987, 329 (6135) : 164 - 167
  • [5] COMMON WEST AFRICAN HLA ANTIGENS ARE ASSOCIATED WITH PROTECTION FROM SEVERE MALARIA
    HILL, AVS
    ALLSOPP, CEM
    KWIATKOWSKI, D
    ANSTEY, NM
    TWUMASI, P
    ROWE, PA
    BENNETT, S
    BREWSTER, D
    MCMICHAEL, AJ
    GREENWOOD, BM
    [J]. NATURE, 1991, 352 (6336) : 595 - 600
  • [6] HOFFMAN SL, 1996, MULARIA VACCINE DEV, pCH3
  • [7] PROTECTION AGAINST MALARIA BY VACCINATION WITH SPOROZOITE SURFACE PROTEIN-2 PLUS CS PROTEIN
    KHUSMITH, S
    CHAROENVIT, Y
    KUMAR, S
    SEDEGAH, M
    BEAUDOIN, RL
    HOFFMAN, SL
    [J]. SCIENCE, 1991, 252 (5006) : 715 - 718
  • [8] CHARACTERIZATION OF PLASMODIUM-FALCIPARUM SPOROZOITE SURFACE PROTEIN-2
    ROGERS, WO
    MALIK, A
    MELLOUK, S
    NAKAMURA, K
    ROGERS, MD
    SZARFMAN, A
    GORDON, DM
    NUSSLER, AK
    AIKAWA, M
    HOFFMAN, SL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) : 9176 - 9180
  • [9] PROTECTION AGAINST MALARIA BY IMMUNIZATION WITH PLASMID DNA ENCODING CIRCUMSPOROZOITE PROTEIN
    SEDEGAH, M
    HEDSTROM, R
    HOBART, P
    HOFFMAN, SL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) : 9866 - 9870
  • [10] WEISS WR, 1989, J IMMUNOL, V143, P4263